Compare $CLDI vs $ERNA | Chartloom

Compare

$CLDI vs $ERNA

Calidi Biotherapeutics Inc · Ernexa Therapeutics Inc

CLDI

Calidi Biotherapeutics Inc

ERNA

Ernexa Therapeutics Inc

Compare $CLDI vs $ERNA

Comparing Calidi Biotherapeutics Inc and Ernexa Therapeutics Inc

CLDICalidi Biotherapeutics Inc

ERNAErnexa Therapeutics Inc

CLDICalidi Biotherapeutics Inc

Market cap

$20M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-94.5%

52W performance

-96.0%

FCF yield

-89.7%

ERNAErnexa Therapeutics Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-91.7%

52W performance

-93.0%

FCF yield

-316.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLDI

ERNA

Detailed metrics comparison

CLDI

Calidi Biotherapeutics Inc

ERNA

Ernexa Therapeutics Inc

Market Cap

CLDI$20M

ERNA$3M

Enterprise Value

CLDI$17M

ERNA$-2M

Price

CLDI$1.03

ERNA$2.40

P/E Ratio

CLDIN/A

ERNAN/A

P/S Ratio

CLDI0.00x

ERNA8.30x

EV/Sales

CLDI0.00x

ERNA0.09x

EV/EBITDA

CLDI0.00x

ERNA0.00x

P/B Ratio

CLDI1.27x

ERNA1.51x

P/FCF Ratio

CLDIN/A

ERNAN/A

EV/FCF

CLDI-0.94x

ERNA0.22x

PEG Ratio

CLDIN/A

ERNAN/A

Forward P/E (NTM)

CLDIN/A

ERNAN/A

Forward P/S (NTM)

CLDIN/A

ERNAN/A

Revenue (TTM)

CLDI$0

ERNA$0

Revenue Growth (YoY)

CLDIN/A

ERNAN/A

Forward Rev Growth

CLDI0.0%

ERNA0.0%

Gross Margin (TTM)

CLDI0.0%

ERNA83.5%

Operating Margin (TTM)

CLDI0.0%

ERNA0.0%

EBITDA Margin (TTM)

CLDI0.0%

ERNA0.0%

Net Margin (TTM)

CLDI0.0%

ERNA0.0%

FCF Margin (TTM)

CLDIN/A

ERNAN/A

Net Income (TTM)

CLDI$-23M

ERNA$-3M

FCF (TTM)

CLDI$-18M

ERNA$-9M

EPS (TTM)

CLDI-$265.03

ERNA$0.00

ROE (TTM)

CLDI-37285.0%

ERNA-16940.0%

ROA (TTM)

CLDI-17613.0%

ERNA-22854.0%

ROIC (TTM)

CLDI-30694.0%

ERNA-15802.0%

Cash

CLDI$4M

ERNA$5M

Debt

CLDI$928K

ERNA$250K

Net Cash/Debt

CLDI$3M

ERNA$5M

Current Ratio (TTM)

CLDI1.68x

ERNA2.01x

Quick Ratio (TTM)

CLDI1.55x

ERNA1.74x

Debt/Equity (TTM)

CLDI0.30x

ERNA0.08x

Debt/Assets (TTM)

CLDI0.0%

ERNA0.0%

Interest Coverage (TTM)

CLDIN/A

ERNAN/A

Net Debt/EBITDA (TTM)

CLDI0.00x

ERNA0.00x

Beta

CLDI1.37

ERNA2.68

52W Performance

CLDI-96.0%

ERNA-93.0%

YTD Performance

CLDI-94.5%

ERNA-91.7%

% from 52W High

CLDI-96.3%

ERNA-96.6%

% from 52W Low

CLDI4.5%

ERNA13.2%

Asset Turnover (TTM)

CLDI0.00x

ERNA0.02x

FCF Yield (TTM)

CLDI-89.7%

ERNA-316.2%

Earnings Yield (TTM)

CLDI-117.9%

ERNA-97.9%

Dividend Yield (TTM)

CLDIN/A

ERNA0.4%

Rule of 40

CLDI0.0

ERNA0.0

EV/GP/RG

CLDIN/A

ERNAN/A

Ticker research

View CLDI research View ERNA research

Metric	CLDI Calidi Biotherapeutics Inc	ERNA Ernexa Therapeutics Inc
Market & Valuation
Market Cap	$20M	$3M
Enterprise Value	$17M	$-2M
Price	$1.03	$2.40
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	8.30x
EV/Sales	0.00x	0.09x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	1.51x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	0.22x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	83.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-23M	$-3M
FCF (TTM)	$-18M	$-9M
EPS (TTM)	-$265.03	$0.00
ROE (TTM)	-37285.0%	-16940.0%
ROA (TTM)	-17613.0%	-22854.0%
ROIC (TTM)	-30694.0%	-15802.0%
Financial Health
Cash	$4M	$5M
Debt	$928K	$250K
Net Cash/Debt	$3M	$5M
Current Ratio (TTM)	1.68x	2.01x
Quick Ratio (TTM)	1.55x	1.74x
Debt/Equity (TTM)	0.30x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	2.68
52W Performance	-96.0%	-93.0%
YTD Performance	-94.5%	-91.7%
% from 52W High	-96.3%	-96.6%
% from 52W Low	4.5%	13.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-89.7%	-316.2%
Earnings Yield (TTM)	-117.9%	-97.9%
Dividend Yield (TTM)	N/A	0.4%
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLDI research	View ERNA research

Valuation

P/S Ratio

CLDI

0.00x

ERNA

8.30x

EV/FCF

CLDI

-0.94x

ERNA

0.22x

Growth & revenue

Forward Revenue Growth

CLDI

0.0%

ERNA

0.0%

Profitability & performance

Gross Margin

ERNA

83.5%

CLDI

0.0%

ROE

ERNA

-16940.0%

CLDI

-37285.0%

FCF Yield %

CLDI

-89.7%

ERNA

-316.2%

52-Week Performance

ERNA

-93.0%

CLDI

-96.0%

Detailed metrics comparison

CLDI

Calidi Biotherapeutics Inc

ERNA

Ernexa Therapeutics Inc

Market Cap

CLDI$20M

ERNA$3M

Enterprise Value

CLDI$17M

ERNA$-2M

Price

CLDI$1.03

ERNA$2.40

P/E Ratio

CLDIN/A

ERNAN/A

P/S Ratio

CLDI0.00x

ERNA8.30x

EV/Sales

CLDI0.00x

ERNA0.09x

EV/EBITDA

CLDI0.00x

ERNA0.00x

P/B Ratio

CLDI1.27x

ERNA1.51x

P/FCF Ratio

CLDIN/A

ERNAN/A

EV/FCF

CLDI-0.94x

ERNA0.22x

PEG Ratio

CLDIN/A

ERNAN/A

Forward P/E (NTM)

CLDIN/A

ERNAN/A

Forward P/S (NTM)

CLDIN/A

ERNAN/A

Revenue (TTM)

CLDI$0

ERNA$0

Revenue Growth (YoY)

CLDIN/A

ERNAN/A

Forward Rev Growth

CLDI0.0%

ERNA0.0%

Gross Margin (TTM)

CLDI0.0%

ERNA83.5%

Operating Margin (TTM)

CLDI0.0%

ERNA0.0%

EBITDA Margin (TTM)

CLDI0.0%

ERNA0.0%

Net Margin (TTM)

CLDI0.0%

ERNA0.0%

FCF Margin (TTM)

CLDIN/A

ERNAN/A

Net Income (TTM)

CLDI$-23M

ERNA$-3M

FCF (TTM)

CLDI$-18M

ERNA$-9M

EPS (TTM)

CLDI-$265.03

ERNA$0.00

ROE (TTM)

CLDI-37285.0%

ERNA-16940.0%

ROA (TTM)

CLDI-17613.0%

ERNA-22854.0%

ROIC (TTM)

CLDI-30694.0%

ERNA-15802.0%

Cash

CLDI$4M

ERNA$5M

Debt

CLDI$928K

ERNA$250K

Net Cash/Debt

CLDI$3M

ERNA$5M

Current Ratio (TTM)

CLDI1.68x

ERNA2.01x

Quick Ratio (TTM)

CLDI1.55x

ERNA1.74x

Debt/Equity (TTM)

CLDI0.30x

ERNA0.08x

Debt/Assets (TTM)

CLDI0.0%

ERNA0.0%

Interest Coverage (TTM)

CLDIN/A

ERNAN/A

Net Debt/EBITDA (TTM)

CLDI0.00x

ERNA0.00x

Beta

CLDI1.37

ERNA2.68

52W Performance

CLDI-96.0%

ERNA-93.0%

YTD Performance

CLDI-94.5%

ERNA-91.7%

% from 52W High

CLDI-96.3%

ERNA-96.6%

% from 52W Low

CLDI4.5%

ERNA13.2%

Asset Turnover (TTM)

CLDI0.00x

ERNA0.02x

FCF Yield (TTM)

CLDI-89.7%

ERNA-316.2%

Earnings Yield (TTM)

CLDI-117.9%

ERNA-97.9%

Dividend Yield (TTM)

CLDIN/A

ERNA0.4%

Rule of 40

CLDI0.0

ERNA0.0

EV/GP/RG

CLDIN/A

ERNAN/A

Ticker research

View CLDI research View ERNA research

Metric	CLDI Calidi Biotherapeutics Inc	ERNA Ernexa Therapeutics Inc
Market & Valuation
Market Cap	$20M	$3M
Enterprise Value	$17M	$-2M
Price	$1.03	$2.40
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	8.30x
EV/Sales	0.00x	0.09x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	1.51x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	0.22x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	83.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-23M	$-3M
FCF (TTM)	$-18M	$-9M
EPS (TTM)	-$265.03	$0.00
ROE (TTM)	-37285.0%	-16940.0%
ROA (TTM)	-17613.0%	-22854.0%
ROIC (TTM)	-30694.0%	-15802.0%
Financial Health
Cash	$4M	$5M
Debt	$928K	$250K
Net Cash/Debt	$3M	$5M
Current Ratio (TTM)	1.68x	2.01x
Quick Ratio (TTM)	1.55x	1.74x
Debt/Equity (TTM)	0.30x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	2.68
52W Performance	-96.0%	-93.0%
YTD Performance	-94.5%	-91.7%
% from 52W High	-96.3%	-96.6%
% from 52W Low	4.5%	13.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-89.7%	-316.2%
Earnings Yield (TTM)	-117.9%	-97.9%
Dividend Yield (TTM)	N/A	0.4%
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLDI research	View ERNA research